| 2001N |
| 1. Tatsumi K, Taki T, Taniwaki M, Nakamura H, Taguchi J, Chen YZ, Bessho F, Yanagisawa M, Hayashi Y: The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines. Genes Chromosomes Cancer 30:230-235, 2001 Abstract |
| 2. Jamal R, Taketani T, Taki T, Bessho F, Hongo T, Hamaguchi H, Horiike S, Taniwaki M, Hanada R, Nakamura H, Hayashi Y: Co-duplication of the MLL and FLT3 Gene in Patients with Acute Myeloid Leukemia. Genes Chromosomes Cancer 31: 187-190, 2001 Abstract |
| 3. Niitsu N, Hayashi Y, Sugita K, Honma Y: Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and1alpha, 25-dihydroxyvitamin D3. Br J Haematol 112:315-326, 2001 Abstract |
| 4. Niitsu N, Hayashi Y, Honma Y: Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13). Oncogene 20: 375-384, 2001 Abstract |
| 5. Murata T, Kurokawa R, Krones A, Tatsumi Ken, Ishii M, Taki T, Masuno M, Ohashi H, Yanagisawa M, Rosenfeld MG, Glass CK, Hayashi Y: Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP may cause Rubinstein-Taybi syndrome. Hum Mol Genet 10: 1071-1076, 2001 Abstract |
| 6. Liu M, Taketani T, Li R, Takita J, Taki T, Yang HW, Kawaguchi H, Ida K, Matsuo Y, Hayashi Y. Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation. Leuk Res 25: 441-447, 2001 Abstract |
@